Interferon beta (IFN-beta)

Neonatal death (< 28 days of life)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S3716
R7997
Thiel (control unexposed, sick), 2016 Early neonatal death (occurring during the first 7 days of life) early pregnancy prospective cohort unexposed, sick Adjustment: No 2.33 [0.09;57.43] C 1/251   0/194 1 251
ref
S3636
R7515
Fragoso b (control exposed to Glatiramer), 2013 Neonatal death (NOS) at least 1st trimester retrospective cohort exposed to other treatment, sick Adjustment: No 0.80 [0.03;20.62] C 0/17   1/41 1 17
ref
Total 2 studies 1.37 [0.14;13.46] 2 268
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Thiel (control unexposed, sick), 2016Thiel, 2016 1 2.33[0.09; 57.43]125151%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Fragoso b (control exposed to Glatiramer), 2013Fragoso b, 2013 2 0.80[0.03; 20.62]11749%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Total (2 studies) I2 = 0% 1.37[0.14; 13.46]22680.25.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: control unexposed, sick; 2: control exposed to Glatiramer;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.37[0.14; 13.46]22680%NAThiel (control unexposed, sick), 2016 Fragoso b (control exposed to Glatiramer), 2013 2 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 2.33[0.09; 57.43]1251 -NAThiel (control unexposed, sick), 2016 1 exposed to other treatment, sickexposed to other treatment, sick 0.80[0.03; 20.62]117 -NAFragoso b (control exposed to Glatiramer), 2013 1 Tags Adjustment   - No  - No 1.37[0.14; 13.46]22680%NAThiel (control unexposed, sick), 2016 Fragoso b (control exposed to Glatiramer), 2013 2 All studiesAll studies 1.37[0.14; 13.46]22680%NAThiel (control unexposed, sick), 2016 Fragoso b (control exposed to Glatiramer), 2013 20.25.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed, sick controlsunexposed, sick controls 2.33[0.09; 57.43]1251 -NAThiel (control unexposed, sick), 2016 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls 0.80[0.03; 20.62]117 -NAFragoso b (control exposed to Glatiramer), 2013 10.510.01.0